The CellSearch™ System is an advanced diagnostic platform used for cancer that offers
real-time tumor biology information through direct assessment of CTCs.
Combining high accuracy, specificity, and reproducibility with state-of-the-art
automation, the CellSearch™ System is the only laboratory platform that standardizes
sample collection, cell capture, staining, enumeration, and characterization of
CTCs.
CellTracks, CellTracks AutoPrep system, Magnest and AutoPrep are registered trademarks
of Immunivest Corporation, a wholly owned subsidiary of Immunicon Corporation.
This product and/or associated components thereof, and procedures and instrument
systems described herein, are protected by United States patents and corresponding
international patents and pending patent applications, owned by Immunivest Corporation,
a wholly owned subsidiary of Immunicon Corporation, and include one or more of the
following: US Patent Numbers, 5,466,574; 5,512,332; 5,597,531; 5,698,271; 5,985,153;
5,993,665; 6,120,856; 6,136,182; 6,365,362; 6,551,843; 6,620,627; 6,623,982; 6,645,731;
6,660,159; 6,790,366; 6,861,259; 6,890,426; 7,011,794; 7,282,350 and 7,332,288.
Certain components are licensed to Immunicon Corporation from Streck Laboratories,
Inc., La Vista, NE, US Patent Numbers 5,849,517 and 5,459,073.
|